Valuation: Zynex, Inc.

Market Cap 3.83M 3.36M 3.13M 2.87M 5.39M 369M 5.48M 37.14M 14.51M 181M 14.37M 14.06M 627M P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 38.02M 33.39M 31.06M 28.5M 53.55M 3.66B 54.37M 369M 144M 1.8B 143M 140M 6.22B EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
1 day+5.77%
6 months-31.25%
Current year-56.35%
Current year 0.02
Extreme 0.0203
0.13
1 year 0.02
Extreme 0.0203
2.63
3 years 0.02
Extreme 0.0203
13.77
5 years 0.02
Extreme 0.0203
17.25
10 years 0.02
Extreme 0.0203
27.02
Manager TitleAgeSince
Chief Executive Officer 53 18/08/2025
Director of Finance/CFO 50 18/08/2025
General Counsel 53 18/08/2025
Director TitleAgeSince
Director/Board Member 50 26/03/2026
Director/Board Member 53 26/03/2026
Date Insider Type Main position Quantity % Market Cap.
26/03/26 Issuer sale

Director

95,000 0.3126%
26/03/26 Issuer sale

Director

80,001 0.2633%
26/03/26 Issuer sale

Director

102,000 0.3357%
Change 5-day change 1-year change 3-year change Capi.($)
+5.77%-.--%-97.83%-99.41% 1.69M
-0.71%+6.72%+19.63%-0.57% 211B
-0.52%-6.05%-5.58%-25.77% 135B
+1.65%-2.29%-30.93%+4.31% 119B
+1.54%+0.50%-58.34%-15.18% 65.77B
-1.42%-3.62%+9.01%-9.60% 47.58B
+3.03%-0.17%-26.81%-31.58% 44.44B
-0.84%+5.41%+15.14%+8.50% 39.14B
-2.02%+1.54%+25.53%+30.56% 36.79B
-1.41%+3.99%+80.31%+3.20% 29.37B
Average +0.51%-1.88%-6.98%-13.55% 72.81B
Weighted average by Cap. -0.00%+0.37%-1.38%-6.02%

Financials

2023 2024
Net sales 184M 162M 151M 138M 260M 17.75B 264M 1.79B 698M 8.73B 692M 677M 30.17B 192M 169M 157M 144M 271M 18.52B 275M 1.87B 729M 9.11B 722M 707M 31.49B
Net income 9.73M 8.55M 7.95M 7.29M 13.71M 937M 13.92M 94.39M 36.88M 461M 36.53M 35.75M 1.59B 2.99M 2.63M 2.45M 2.24M 4.22M 288M 4.28M 29.04M 11.35M 142M 11.24M 11M 490M
Net Debt 31.59M 27.74M 25.8M 23.68M 44.49M 3.04B 45.17M 306M 120M 1.5B 119M 116M 5.17B 34.19M 30.03M 27.93M 25.63M 48.15M 3.29B 48.9M 332M 130M 1.62B 128M 126M 5.6B
Logo Zynex, Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
1,000
  1. Stock Market
  2. Stocks
  3. ZYXI Stock